Search the Newsreel

Grupo Televisa's Q2 Earnings: What May Matter Most Is Not In The Report (NYSE:TV)

BrightView Holdings, Inc. Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next

BrightView Holdings (NYSE: BV) recently reported a surprise Q3 2026 loss, missing analyst revenue estimates and causing its share price to drop 17% in a single day. Despite the miss, analysts are maintaining a positive outlook with an average price target of US$14.80, suggesting …

BrightView Holdings, Inc. Revenue Breakdown – LSX:A2JPBC

This article provides a revenue breakdown for BrightView Holdings, Inc. (LSX:A2JPBC), highlighting its top-performing segment and geographical contribution. Last year, the company generated 2.28 billion EUR in revenue, with the Maintenance Services segment contributing the most at 1.61 billion EUR. The United States was …

BofA Adjusts Price Target on FrontView REIT to $19 From $17

BofA has adjusted its price target for FrontView REIT (FVR) from $17 to $19. This news follows several other analyst adjustments and company announcements, including FrontView REIT's Q2 2026 earnings call, dividend declaration, and additions to Russell indexes.

テレ朝ＨＤ(9409) [Summary]TV Asahi Holdings Corporation Consolidated Financial Results for the Three Months Ended June 30, 2026 (Under Japanese GAAP) 2026年08月07日[適時開示]

FVR Stock Price and Chart — NYSE:FVR

This article provides a detailed overview of FrontView REIT, Inc. (FVR) stock, including its current price, historical performance, key financial metrics, and analyst ratings. It highlights the company's business model of acquiring and managing net-leased outparcel properties and offers answers to frequently asked questions …

vTv Therapeutics Inc.: vTv Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

vTv Therapeutics Inc. has reported its financial results for the second quarter ended June 30, 2026, and provided a corporate update. The company expects to complete enrollment in its Phase 3 CATT1 trial for cadisegliatin, a treatment for type 1 diabetes, in Q3 2026 …

FrontView REIT, Inc. Q2 2026: Revenue $18M, EPS $0.26— 10-Q Summary

BrightView Holdings (NYSE: BV) director adds 50,000 shares through trusts

BrightView Holdings (NYSE: BV) director William L. Cornog purchased 50,000 shares of common stock on August 6, 2026, through trusts for his children and a living trust. These transactions occurred at weighted-average prices of $11.25 and $11.24 per share, contributing to his indirect holdings. …

Analysts’ Top Industrial Goods Picks: BrightView Holdings (BV), BWX Technologies (BWXT)

Analysts have issued neutral ratings for BrightView Holdings (BV) and BWX Technologies (BWXT), indicating neither a bullish nor bearish stance. Goldman Sachs maintained a Hold rating on BrightView with a price target of $10.80, while Maxim Group maintained a Hold rating on BWX Technologies. …

FrontView Q2 2026 slides: diversification drives growth amid skepticism

FrontView REIT (NASDAQ:FVR) delivered strong second-quarter 2026 results, raising its full-year AFFO per share guidance to $1.32-$1.34, despite a 4.06% stock decline post-earnings. The company emphasized its diversified portfolio, disciplined capital allocation, and strong operational efficiency, including a low dividend payout ratio and conservative …

Earnings call transcript: FrontView tops Q2 2026 EPS forecast, shares fall

FrontView (FVR) reported stronger-than-expected Q2 2026 adjusted EPS of $0.03, beating analyst forecasts for a loss of $0.04, with revenue at $18.01 million. Despite the earnings beat and raised full-year AFFO per share guidance, the stock fell 3.69% in premarket trading, suggesting investors were …

BrightView Holdings, Inc. Stock 12‑Month Price Target Cut to $16.35, Implies 25% Upside

BrightView Holdings, Inc. (BV) has seen its average 12-month price target reduced from $16.68 to $16.35 by 10 analysts, with individual forecasts ranging from $10 to $24 per share. Despite the cut, this updated target still suggests a potential upside of approximately 25% from …

FrontView REIT Q2 2026 Earnings Call Highlights

FrontView REIT reported strong Q2 2026 results, including a $200,000 sequential increase in base rent and a raised 2026 AFFO per share guidance to $1.32-$1.34. The company also raised $50.50 million through an ATM program and acquired 17 properties for $58.2 million, demonstrating active …

fuboTV Inc (FUBO) News, Articles, Events & Latest Updates

This article compiles recent news and updates for fuboTV Inc (FUBO), highlighting its Q3 2026 financial results which showed a loss and missed revenue estimates, despite narrowing losses and record North America subscribers. Key announcements include the appointment of Alisa Bowen as CEO and …

Press Release: FrontView REIT Announces Second Quarter 2026 Results and Raises 2026 Net Investment and AFFO per Share Guidance

FrontView REIT announced its second-quarter 2026 results, reporting significant financial growth. The company reported a net income of $222.8 million and diluted earnings per share of $1.51, along with a 13.9% increase in Adjusted Funds From Operations (AFFO) per share to $1.39. Following these …

Oppenheimer Adjusts PT on BrightView Holdings to $16 From $17, Maintains Outperform Rating

Oppenheimer has adjusted its price target for BrightView Holdings (BV) to $16 from the previous $17, while reiterating an Outperform rating on the stock. This update reflects a re-evaluation of the company's financial outlook by the analyst firm. The article also provides a company …

FuboTV Stock: Turnaround In Place, But Value Trap Remains A Fear (NYSE:FUBO)

FuboTV Inc. is demonstrating signs of business momentum and a more promising profit picture following its reverse stock split. The company has raised its FY26 adjusted EBITDA target to $90–$100 million, with ambitions to reach $300 million by FY28, partially due to a partnership …

vTv expects type 1 diabetes trial enrollment to finish in Q3 2026

vTv Therapeutics announced its Q2 2026 financial results, reporting a net loss of $13.1 million but maintaining sufficient cash to fund operations through the anticipated topline data readout of its Phase 3 CATT1 trial. Enrollment for the CATT1 trial, which evaluates cadisegliatin for type …

Morgan Stanley Adjusts PT on BrightView Holdings to $12.50 From $14, Maintains Equalweight Rating

Morgan Stanley has lowered its price target for BrightView Holdings (BV) to $12.50 from $14, while keeping an Equalweight rating on the stock. This adjustment comes after BrightView Holdings reported its Q3 2026 earnings, posting an adjusted EPS of $0.17, which was below FactSet's …

BrightView Holdings, Inc. (NYSE:BV) Receives Average Recommendation of "Hold" from Analysts

BrightView Holdings, Inc. (NYSE:BV) has received an average "Hold" recommendation from analysts, with a consensus 12-month price target of $14.35. The company's fiscal Q3 revenue increased 1.3% year-over-year but missed estimates, and profitability significantly weakened with adjusted EBITDA and net income falling. Management provided …

First Trust Advisors LP Purchases 100,420 Shares of BrightView Holdings, Inc. $BV

First Trust Advisors LP increased its stake in BrightView Holdings, Inc. (NYSE:BV) by 42.7% in the first quarter, acquiring an additional 100,420 shares and bringing its total holdings to 335,460 shares valued at $3,955,000. Other institutional investors also adjusted their positions in BrightView. The …

vTv Therapeutics (NASDAQ:VTVT) Price Target Lowered to $42.00 at HC Wainwright

FrontView REIT (FVR) Earnings Date and Reports 2026 $FVR

FrontView REIT (NYSE: FVR) back to profit and adds 27 properties

vTv Therapeutics (NASDAQ:VTVT) Posts Earnings Results, Misses Expectations By $0.08 EPS

FrontView REIT, Inc. (FVR) Q2 FFO Meet Estimates

FuboTV (FUBO) Stock Gains Momentum As Losses Narrow And Revenue Climbs

Grupo Televisa, S.A.B. Sponsored ADR Revenue Breakdown – LS:888781

Grupo Televisa, S.A.B. Sponsored ADR (LS:888781) generated 2.88 billion EUR in revenue last year, with its Telecom segment being the highest contributor at 2.61 billion EUR. Mexico was the largest regional contributor, accounting for 2.56 billion EUR last year. The article provides a breakdown …

Grupo Televisa Renews Market Maker Agreement for Mexican Shares

Grupo Televisa, S.A.B. has renewed its market maker agreement with Santander Casa de Bolsa for its shares traded on the Mexican Stock Exchange under the ticker TLEVISA CPO. This agreement, valid until August 8, 2027, aims to boost liquidity and orderly trading for its …

FuboTV Inc. Q2 2026: Revenue $1.48B, EPS ($0.25) — 10-Q Summary

FuboTV Inc. reported its Q2 2026 results, showing a significant year-over-year revenue increase to $1.48 billion and a narrowed net loss with a diluted loss per share of ($0.25). The company attributed this growth to the Fubo integration, new advertising revenue following its business …

fuboTV Inc. Q3 2026 Earnings Call Summary

fuboTV Inc. Q3 2026 Earnings Call Summary - Moby Executive Narrative Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Management attributes the …

BrightView Q3 Earnings Call Highlights

BrightView Holdings, Inc. 2026 Q3 - Results - Earnings Call Presentation (NYSE:BV) 2026-08-05

BrightView Holdings, Inc. (BV) has published its Q3 2026 earnings call presentation. The company reported an EPS of $0.17, missing estimates by $0.12, and revenue of $717.60 million, missing by $8.88 million, despite a 1.31% year-over-year increase. This article provides access to the slide …

FuboTV (FUBO) Faces A Valuation Test As Losses Narrow After Third Quarter Results

fuboTV supera pronóstico de EPS en Q3 2026 y sus acciones suben 5%